Understanding how chaperones prevent Alzheimer's disease
Towards the understanding of how chaperones function and prevent amyloidogenic diseases
['FUNDING_OTHER'] · UNIVERSITY OF ARIZONA · NIH-11009591
This study is looking at how certain helper proteins can stop harmful protein clumps that are linked to Alzheimer's disease, and it hopes to find new ways to protect brain health for people living with this condition.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF ARIZONA (nih funded) |
| Locations | 1 site (TUCSON, UNITED STATES) |
| Trial ID | NIH-11009591 on ClinicalTrials.gov |
What this research studies
This research investigates the role of chaperone proteins, specifically Hsp60 and Hsp70, in preventing the aggregation of proteins associated with Alzheimer's disease. By exploring how these proteins function within mitochondria, the study aims to uncover mechanisms that could protect against the toxic effects of misfolded proteins. The research will involve analyzing the structure of these chaperones during their protein folding cycle to better understand their protective capabilities. Patients may benefit from insights that could lead to new therapeutic strategies for Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it.
Not a fit: Patients with other forms of dementia unrelated to protein misfolding may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that slow or prevent the progression of Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in understanding the role of chaperones in neurodegenerative diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
TUCSON, UNITED STATES
- UNIVERSITY OF ARIZONA — TUCSON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HEGETSCHWEILER, MARIELLE AULIKKI — UNIVERSITY OF ARIZONA
- Study coordinator: HEGETSCHWEILER, MARIELLE AULIKKI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.